Skip to content

Transcranial Magnetic Stimulation for BECTS

Impact of Repetitive Transcranial Magnetic Stimulation (TMS) on Spike Frequency and Brain Connectivity in Children With Benign Epilepsy With Centrotemporal Spike (BECTS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04325282
Acronym
TMS4BECTS
Enrollment
22
Registered
2020-03-27
Start date
2020-10-28
Completion date
2024-03-03
Last updated
2025-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Epilepsy With Centrotemporal Spikes, Language Problems, Learning Disorders

Keywords

Transcranial Magnetic Stimulation (TMS), Electroencephalogram (EEG), Children, Pediatric, Interictal Epileptiform Discharges, Brain connectivity

Brief summary

Benign epilepsy with centrotemporal spikes (BECTS) is the most common pediatric epilepsy syndrome. Affected children typically have a mild seizure disorder, but yet have moderate difficulties with language, learning and attention that impact quality of life more than the seizures. Separate from the seizures, these children have very frequent abnormal activity in their brain known as interictal epileptiform discharges (IEDs, or spikes), which physicians currently do not treat. These IEDs arise near the motor cortex, a region in the brain that controls movement. In this study, the investigators will use a form of non-invasive brain stimulation called transcranial magnetic stimulation (TMS) to determine the impact of IEDs on brain regions important for language to investigate: (1) if treatment of IEDs could improve language; and (2) if brain stimulation may be a treatment option for children with epilepsy. Participating children will wear electroencephalogram (EEG) caps to measure brain activity. The investigators will use TMS to stimulate the brain region where the IEDs originate to measure how this region is connected to other brain regions. Children will then receive a special form of TMS called repetitive TMS (rTMS) that briefly reduces brain excitability. The study will measure if IEDs decrease and if brain connectivity changes after rTMS is applied. The investigators hypothesize that the IEDs cause language problems by increasing connectivity between the motor cortex and language regions. The investigators further hypothesize that rTMS will reduce the frequency of IEDs and also reduce connectivity between the motor and language region

Interventions

DEVICEActive rTMS

1Hz rTMS delivered for 15-20 minutes

DEVICESham rTMS

sham rTMS delivered for 15-20 minutes

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH
Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Children will receive active repetitive TMS (rTMS) on one day and sham stimulation on a second day. The order of stimulation will be randomized on a per-participant basis. Children and parents/guardians will not be told if they are receiving sham or inhibitory rTMS on a given day. The research team will know at the time of stimulation, however, as they will have to choose which coil to use. The TMS-EEG files will be coded and the team member analyzing the files for change in IED (spike) frequency and change in connectivity will be blinded to condition.

Eligibility

Sex/Gender
ALL
Age
5 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* A diagnosis of Benign Epilepsy with Centrotemporal Spikes (BECTS), sometimes called Rolandic Epilepsy. Diagnosis will be based on a history of a focal motor seizure (affecting the face or causing hypersalivation) or a history of a seizure out of sleep AND an EEG with unilateral or bilateral centrotemporal spike waves. * English-speaking

Exclusion criteria

* History of prematurity \< 35 weeks gestational age; * History of serious neurologic problems (i.e. history of other seizure disorder other than simple febrile seizure, head trauma with prolonged loss of consciousness, cerebrovascular accident or neuro-inflammatory disease) * Focal deficits on neurologic exam * History of abnormal MRI (with clear gray or white matter abnormality)

Design outcomes

Primary

MeasureTime frameDescription
Interictal Epileptiform Discharge (IED) FrequencyBefore and after intervention (approximately 4 hours/visit on 2 study days one week apart)We will count the number of IEDs/minute before and after application of active rTMS as well as before and after sham rTMS. We will compare the change in IEDs induced by the active and sham stimulation.

Secondary

MeasureTime frameDescription
Change in Brain ConnectivityBefore and after intervention (approximately 4 hours/visit on 2 study days one week apart)We will measure brain connectivity before and after application of active rTMS as well as before and after sham rTMS. We will compare the change in connectivity induced by the active and sham stimulation. In particular, we will look at how connectivity changes between the motor cortex and language regions of the brain. We chose 3 regions of interest per hemisphere (-F: Frontal, -M: Motor, -T: Temporal). rTMS was applied to the hemisphere with more spikes on clinical EEG, and hence all regions were further qualified as being ipsilateral (i-) or contralateral (c-) to rTMS application. Connectivity is measured in the weighted Phase Lag Index (wPLI) in the beta-frequency band, a phase-based connectivity measure which runs from a theoretical minimum of 0 (no connectivity) to 1 (complete connectivity).

Countries

United States

Participant flow

Recruitment details

This study enrolled participants with Self Limited Epilepsy with Centrotemporal Spikes (SeLECTS), formerly known as Benign Epilepsy with Centrotemporal Spikes (BECTS).

Participants by arm

ArmCount
Children With SeLECTS - Active, Then Sham rTMS
Children will receive sham and active (1 Hz) rTMS on 2 separate study visits separated by at least 1 week.
11
Children With SeLECTS - Sham, Then Active rTMS
Children will receive sham and active (1 Hz) rTMS on 2 separate study visits separated by at least 1 week.
8
Total19

Withdrawals & dropouts

PeriodReasonFG000FG001
First Intervention (1 Day)Withdrawal by Subject01
Second Intervention (1 Day)Withdrawal by Subject01

Baseline characteristics

CharacteristicChildren With SeLECTS - Active, Then Sham rTMSTotalChildren With SeLECTS - Sham, Then Active rTMS
Age, Continuous9.6 years
STANDARD_DEVIATION 1.4
9.8 years
STANDARD_DEVIATION 1.6
10.1 years
STANDARD_DEVIATION 1.8
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants3 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants16 Participants6 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants4 Participants3 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
10 Participants14 Participants4 Participants
Region of Enrollment
United States
11 Participants19 Participants8 Participants
Sex: Female, Male
Female
1 Participants5 Participants4 Participants
Sex: Female, Male
Male
10 Participants14 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 190 / 19
other
Total, other adverse events
2 / 190 / 19
serious
Total, serious adverse events
0 / 190 / 19

Outcome results

Primary

Interictal Epileptiform Discharge (IED) Frequency

We will count the number of IEDs/minute before and after application of active rTMS as well as before and after sham rTMS. We will compare the change in IEDs induced by the active and sham stimulation.

Time frame: Before and after intervention (approximately 4 hours/visit on 2 study days one week apart)

Population: Participants with Analyzable Data (Remained awake for both active \& sham rTMS sessions)

ArmMeasureGroupValue (MEDIAN)
Children With SeLECTS - Active rTMSInterictal Epileptiform Discharge (IED) FrequencyBefore rTMS0 IEDs per 5 minutes
Children With SeLECTS - Active rTMSInterictal Epileptiform Discharge (IED) FrequencyAfter rTMS0 IEDs per 5 minutes
Children With SeLECTS - Active rTMSInterictal Epileptiform Discharge (IED) FrequencyChange from pre-rTMS to post-rTMS0 IEDs per 5 minutes
Children With SeLECTS - Sham rTMSInterictal Epileptiform Discharge (IED) FrequencyBefore rTMS0 IEDs per 5 minutes
Children With SeLECTS - Sham rTMSInterictal Epileptiform Discharge (IED) FrequencyAfter rTMS0 IEDs per 5 minutes
Children With SeLECTS - Sham rTMSInterictal Epileptiform Discharge (IED) FrequencyChange from pre-rTMS to post-rTMS0 IEDs per 5 minutes
Comparison: Within-group analysis of change after active rTMS (post-rTMS compared to pre-rTMS).p-value: 0.04Wilcoxon signed rank test
Comparison: Within-group analysis of change after sham rTMS (post-rTMS compared to pre-rTMS).p-value: 0.46Wilcoxon signed rank test
Comparison: Between-group analysis of change induced by active rTMS versus sham rTMSp-value: 0.12Wilcoxon signed rank test
Secondary

Change in Brain Connectivity

We will measure brain connectivity before and after application of active rTMS as well as before and after sham rTMS. We will compare the change in connectivity induced by the active and sham stimulation. In particular, we will look at how connectivity changes between the motor cortex and language regions of the brain. We chose 3 regions of interest per hemisphere (-F: Frontal, -M: Motor, -T: Temporal). rTMS was applied to the hemisphere with more spikes on clinical EEG, and hence all regions were further qualified as being ipsilateral (i-) or contralateral (c-) to rTMS application. Connectivity is measured in the weighted Phase Lag Index (wPLI) in the beta-frequency band, a phase-based connectivity measure which runs from a theoretical minimum of 0 (no connectivity) to 1 (complete connectivity).

Time frame: Before and after intervention (approximately 4 hours/visit on 2 study days one week apart)

Population: Participants with Analyzable Data (Remained awake for both active \& sham rTMS sessions)

ArmMeasureGroupValue (MEDIAN)
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in iF-cM Connectivity-0.038566551 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in iT-cT Connectivity-0.041984947 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in iF-iT Connectivity-0.031871907 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in cF-cT Connectivity-0.022140561 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in iF-cT Connectivity-0.017946561 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in cF-cM Connectivity-0.011221254 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in iF-cF Connectivity-0.017828074 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in cF-iM Connectivity-0.031668097 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in iM-cT Connectivity-0.016437136 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in iM-iT Connectivity-0.030898043 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in cM-iT Connectivity-0.026464821 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in cM-cT Connectivity-0.029060306 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in cF-iT Connectivity-0.025147033 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in iM-cM Connectivity-0.032771045 wPLI
Children With SeLECTS - Active rTMSChange in Brain ConnectivityChange in iF-iM Connectivity-0.028419447 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in iM-cM Connectivity0.004707047 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in iF-cF Connectivity0.004773205 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in cF-iT Connectivity0.001240549 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in cM-iT Connectivity0.015413055 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in iF-iT Connectivity0.005724761 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in iM-cT Connectivity0.010533673 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in iF-cT Connectivity0.008023921 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in iF-iM Connectivity0.011937066 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in iT-cT Connectivity-0.000655525 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in cF-cT Connectivity0.006909577 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in cF-cM Connectivity0.009773165 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in cF-iM Connectivity0.01966644 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in iM-iT Connectivity0.002850137 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in cM-cT Connectivity-0.00727134 wPLI
Children With SeLECTS - Sham rTMSChange in Brain ConnectivityChange in iF-cM Connectivity0.009032342 wPLI
Comparison: Within-group analysis of change in cF-iT connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: <0.0001Wilcoxon signed-rank test
Comparison: Within-group analysis of change in cF-iT connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.69Wilcoxon signed rank test
Comparison: Between-group analysis of change in cF-iT connectivity induced by active versus sham rTMS.p-value: <0.0001Wilcoxon signed rank test
Comparison: Within-group analysis of change in cM-iT connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: <0.0001Wilcoxon signed rank test
Comparison: Within-group analysis of change in cM-iT connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.43Wilcoxon signed rank test
Comparison: Between-group analysis of change in cM-iT connectivity induced by active versus sham rTMS.p-value: <0.0001Wilcoxon signed rank test
Comparison: Within-group analysis of change in iF-cM connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.002Wilcoxon signed rank test
Comparison: Within-group analysis of change in iF-cM connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.54Wilcoxon signed rank test
Comparison: Between-group analysis of change in iF-cM connectivity induced by active versus sham rTMS.p-value: 0.007Wilcoxon signed rank test
Comparison: Within-group analysis of change in iF-iT connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.002Wilcoxon signed rank test
Comparison: Within-group analysis of change in iF-iT connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.32Wilcoxon signed rank test
Comparison: Between-group analysis of change in iF-iT connectivity induced by active versus sham rTMS.p-value: 0.01Wilcoxon signed rank test
Comparison: Within-group analysis of change in iF-cF connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.003Wilcoxon signed rank test
Comparison: Within-group analysis of change in iF-cF connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.29Wilcoxon signed rank test
Comparison: Between-group analysis of change in iF-cF connectivity induced by active versus sham rTMS.p-value: 0.02Wilcoxon signed rank test
Comparison: Within-group analysis of change in iM-cT connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.003Wilcoxon signed rank test
Comparison: Within-group analysis of change in iM-cT connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.66Wilcoxon signed rank test
Comparison: Between-group analysis of change in iM-cT connectivity induced by active versus sham rTMS.p-value: 0.008Wilcoxon signed rank test
Comparison: Within-group analysis of change in iF-cT connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.005Wilcoxon signed rank test
Comparison: Within-group analysis of change in iF-cT connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.87Wilcoxon signed rank test
Comparison: Between-group analysis of change in iF-cT connectivity induced by active versus sham rTMS.p-value: 0.11Wilcoxon signed rank test
Comparison: Within-group analysis of change in iF-iM connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.012Wilcoxon signed rank test
Comparison: Within-group analysis of change in iF-iM connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.46Wilcoxon signed rank test
Comparison: Between-group analysis of change in iF-iM connectivity induced by active versus sham rTMS.p-value: 0.02Wilcoxon signed rank test
Comparison: Within-group analysis of change in iT-cT connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.01Wilcoxon signed rank test
Comparison: Within-group analysis of change in iT-cT connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.99Wilcoxon signed rank test
Comparison: Between-group analysis of change in iT-cT connectivity induced by active versus sham rTMS.p-value: 0.04Wilcoxon signed rank test
Comparison: Within-group analysis of change in cF-cT connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.01Wilcoxon signed rank test
Comparison: Within-group analysis of change in cF-cT connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.31Wilcoxon signed rank test
Comparison: Between-group analysis of change in cF-cT connectivity induced by active versus sham rTMS.p-value: 0.05Wilcoxon signed rank test
Comparison: Within-group analysis of change in cF-cM connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.03Wilcoxon signed rank test
Comparison: Within-group analysis of change in cF-cM connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.2Wilcoxon signed rank test
Comparison: Between-group analysis of change in cF-cM connectivity induced by active versus sham rTMS.p-value: 0.04Wilcoxon signed rank test
Comparison: Within-group analysis of change in cF-iM connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.05Wilcoxon signed rank test
Comparison: Within-group analysis of change in cF-iM connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.59Wilcoxon signed rank test
Comparison: Between-group analysis of change in cF-iM connectivity induced by active versus sham rTMS.p-value: 0.12Wilcoxon signed rank test
Comparison: Within-group analysis of change in iM-iT connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.1Wilcoxon signed rank test
Comparison: Within-group analysis of change in iM-iT connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.57Wilcoxon signed rank test
Comparison: Between-group analysis of change in iM-iT connectivity induced by active versus sham rTMS.p-value: 0.06Wilcoxon signed rank test
Comparison: Within-group analysis of change in cM-cT connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.12Wilcoxon signed rank test
Comparison: Within-group analysis of change in cM-cT connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.69Wilcoxon signed rank test
Comparison: Between-group analysis of change in iM-cM connectivity induced by active versus sham rTMS.p-value: 0.04Wilcoxon signed rank test
Comparison: Between-group analysis of change in cM-cT connectivity induced by active versus sham rTMS.p-value: 0.14Wilcoxon signed rank test
Comparison: Within-group analysis of change in iM-cM connectivity during active rTMS (post-rTMS versus pre-rTMS).p-value: 0.12Wilcoxon signed rank test
Comparison: Within-group analysis of change in iM-cM connectivity during sham rTMS (post-rTMS versus pre-rTMS).p-value: 0.6Wilcoxon signed rank test

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026